These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 1745145

  • 21. Specific anti-Bordetella pertussis activities in human blood examined by enzyme-linked immunoassay and biological assay.
    Marley PB, Wilson JV, Habel H, Blaskett A.
    Dev Biol Stand; 1985; 61():341-52. PubMed ID: 2872123
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Characterization and clinical study on the acellular pertussis vaccine produced by a combination of column purified pertussis toxin and filamentous hemagglutinin.
    Ginnaga A, Morokuma K, Aihara K, Sakou M, Imaizumi A, Suzuki Y, Sato H, Sato Y, Ueda K, Kuno-Sakai H.
    Tokai J Exp Clin Med; 1988; 13 Suppl():59-69. PubMed ID: 2908528
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection.
    Shahin RD, Amsbaugh DF, Leef MF.
    Infect Immun; 1992 Apr; 60(4):1482-8. PubMed ID: 1548072
    [Abstract] [Full Text] [Related]

  • 26. A trial of acellular pertussis vaccine in hospital workers during the Cincinnati pertussis epidemic of 1993.
    Christie CD, Garrison KM, Kiely L, Gupta RK, Heubi J, Marchant CD.
    Clin Infect Dis; 2001 Oct 01; 33(7):997-1003. PubMed ID: 11528571
    [Abstract] [Full Text] [Related]

  • 27. Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis.
    Munoz JJ, Arai H, Cole RL.
    Infect Immun; 1981 Apr 01; 32(1):243-50. PubMed ID: 6260681
    [Abstract] [Full Text] [Related]

  • 28. Antibodies to Bordetella pertussis in human colostrum and their protective activity against aerosol infection of mice.
    Oda M, Cowell JL, Burstyn DG, Thaib S, Manclark CR.
    Infect Immun; 1985 Feb 01; 47(2):441-5. PubMed ID: 2857154
    [Abstract] [Full Text] [Related]

  • 29. Separation and purification of the hemagglutinins from Bordetella pertussis.
    Sato Y, Cowell JL, Sato H, Burstyn DG, Manclark CR.
    Infect Immun; 1983 Jul 01; 41(1):313-20. PubMed ID: 6305841
    [Abstract] [Full Text] [Related]

  • 30. The influence of the route of immunization on the protection of mice infected intracerebrally with Bordetella pertussis.
    Standfast AF, Dolby JM.
    J Hyg (Lond); 1972 Sep 01; 70(3):487-501. PubMed ID: 4341998
    [Abstract] [Full Text] [Related]

  • 31. The mitogenic effect of the lymphocytosis promoting factor from Bordetella pertussis on human lymphocytes.
    Morse JH, Kong AS, Lindenbaum J, Morse SI.
    J Clin Invest; 1977 Sep 01; 60(3):683-92. PubMed ID: 197121
    [Abstract] [Full Text] [Related]

  • 32. Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection.
    Jones DH, McBride BW, Thornton C, O'Hagan DT, Robinson A, Farrar GH.
    Infect Immun; 1996 Feb 01; 64(2):489-94. PubMed ID: 8550197
    [Abstract] [Full Text] [Related]

  • 33. Separation and characterization of two distinct hemagglutinins contained in purified leukocytosis-promoting factor from Bordetella pertussis.
    Arai H, Sato Y.
    Biochim Biophys Acta; 1976 Oct 22; 444(3):765-82. PubMed ID: 186106
    [Abstract] [Full Text] [Related]

  • 34. The effect of Bordetella pertussis lymphocytosis-promoting factor (LPF) on antibody response in mice: its enhancing and suppressive effects.
    Asakawa S, Iwasa S.
    Jpn J Med Sci Biol; 1982 Feb 22; 35(1):25-9. PubMed ID: 6285047
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Toxic factors of Bordetella pertussis, with special reference to leukocytosis-promoting factor, histamine-sensitizing factor and hemagglutinins (author's transl)].
    Sato Y.
    Tanpakushitsu Kakusan Koso; 1976 Nov 22; Suppl():164-83. PubMed ID: 194282
    [No Abstract] [Full Text] [Related]

  • 37. Partial purification and some properties of inhibitors to the hemagglutinating activity of leukocytosis-promoting factor (LPF) from Bordetella pertussis [proceedings].
    Arai H, Sato U.
    Jpn J Med Sci Biol; 1978 Apr 22; 31(2):178. PubMed ID: 79665
    [No Abstract] [Full Text] [Related]

  • 38. The active immunization of mice against an intracerebral infection of Haemophilus pertussis organisms by intranasal instillation of H. pertussis antigens.
    BROWN AM.
    J Gen Microbiol; 1953 Feb 22; 8(1):iii. PubMed ID: 13035052
    [No Abstract] [Full Text] [Related]

  • 39. [Hemagglutinin of Hemophilus pertussis. IV. Response reaction of the organism to the action of hemagglutinin in whooping cough infection].
    IVANOVA SP.
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Dec 22; 27(12):23-7. PubMed ID: 13423744
    [No Abstract] [Full Text] [Related]

  • 40. [Ability of adrenaline and desoxycorticosterone to protect mice immunized by Hemophilus pertussis against heightened toxicity of histamine].
    HALPERN BN, BENACERRAF B.
    C R Seances Soc Biol Fil; 1950 Apr 22; 144(7-8):502-3. PubMed ID: 14773053
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.